For example, anti-CD25 treatment in mice inoculated with 4T1 cancer cells strongly reduced tumor growth, which correlated with an increase in DCs and effector CD8+ T cells in tumor-draining lymph nodes (TDLNs), suggesting that Tregs modulate DC function (Goudin et al. 2016). This evidence concerns the gene CD8A and neoplasm.